Genetic Testing Services (RUO)

Targeted, full-genomic next-generation sequencing for research use.

Research use only

ABCA4 Single Gene Sequencing

Specimen2–4 mL of blood with anticoagulant EDTA
Lab methodNext generation sequencing. Our solution entails a targeted full-genomic sequencing approach that enables deep sequencing of a gene's complete genomic sequence, encompassing its enhancers, promoters, exons, shallow introns and, importantly, the deep introns.

Indications for genetic testing

  • Confirmation of clinical diagnosis
  • Carrier testing for at-risk family members
  • Genetic counseling
  • Prenatal diagnosis for known familial mutation

Autosomal recessive Stargardt disease is a juvenile-onset macular dystrophy associated with rapid central visual impairment, progressive bilateral atrophy of the foveal retinal pigment epithelium, and the frequent appearance of yellowish flecks around the macula and/or in the central and near-peripheral areas of the retina.

Research use only

Urea Cycle Disorder (UCD) Panel

Specimen2–4 mL of blood with anticoagulant EDTA
Lab methodNext generation sequencing. The UCD panel encompasses capture probes designed for eight genes, namely ARG1, ASL, ASS1, CPS1, NAGS, OTC, SLC25A13 and SLC25A15. Our solution entails a targeted full-genomic sequencing approach that enables deep sequencing of a gene's complete genomic sequence, encompassing its enhancers, promoters, exons, shallow introns and, importantly, the deep introns.

Indications for genetic testing

  • Confirmation of clinical diagnosis
  • Carrier testing for at-risk family members
  • Genetic counseling
  • Prenatal diagnosis for known familial mutation

Conditions covered by the UCD panel

GeneCondition
ARG1Argininemia
ASLArgininosuccinic aciduria
ASS1Citrullinemia
CPS1Carbamoylphosphate synthetase I deficiency
NAGSN-acetylglutamate synthase deficiency
OTCOrnithine transcarbamylase deficiency
SLC25A13Citrullinemia, adult-onset type II; Citrullinemia, type II, neonatal-onset
SLC25A15Hyperornithinemia–hyperammonemia–homocitrullinemia syndrome
Technology Disclosure

Targeted Full-Genomic Gene Panel as Diagnostics for Genetic Disorders

Developed in collaboration with the A*STAR Institute of Molecular and Cell Biology (IMCB), this technology underpins Camtech's targeted full-genomic sequencing approach — enabling deep sequencing across a gene's complete genomic sequence, including its enhancers, promoters, exons and deep introns, to support diagnostics for genetic disorders such as ABCA4-retinopathy and urea cycle disorders.

Scientific Publications

Peer-reviewed research

Developing splice-switching oligonucleotides for urea cycle disorder using an integrated diagnostic and therapeutic platform

Ow JR, Imagawa E, Chen F, et al. J Hepatol. 2025 Aug;83(2):411–425. doi: 10.1016/j.jhep.2025.02.007

Read the publication →

Contact us for service enquiry

Get in touch to discuss specimen requirements, turnaround time and panel design for your research.